Chemoinformaics analysis of 3-Methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)isoxazole
| Molecular Weight | 205.301 | nRot | 1 |
| Heavy Atom Molecular Weight | 186.149 | nRig | 11 |
| Exact Molecular Weight | 205.147 | nRing | 2 |
| Solubility: LogS | -4.751 | nHRing | 1 |
| Solubility: LogP | 4.182 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 2 | APOL | 36.2811 |
| nHD | 0 | BPOL | 20.7969 |
| QED | 0.693 |
| Synth | 2.87 |
| Natural Product Likeliness | 0.224 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.821 |
| Pgp-sub | 0.002 |
| HIA | 0.009 |
| CACO-2 | -4.652 |
| MDCK | 0.0000085 |
| BBB | 0.542 |
| PPB | 0.952433 |
| VDSS | 4.322 |
| FU | 0.0551678 |
| CYP1A2-inh | 0.96 |
| CYP1A2-sub | 0.916 |
| CYP2c19-inh | 0.791 |
| CYP2c19-sub | 0.692 |
| CYP2c9-inh | 0.634 |
| CYP2c9-sub | 0.835 |
| CYP2d6-inh | 0.739 |
| CYP2d6-sub | 0.866 |
| CYP3a4-inh | 0.157 |
| CYP3a4-sub | 0.382 |
| CL | 1.98 |
| T12 | 0.217 |
| hERG | 0.02 |
| Ames | 0.037 |
| ROA | 0.247 |
| SkinSen | 0.096 |
| Carcinogencity | 0.533 |
| EI | 0.465 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.772728 |